Medline Inc. (MDLN) EV/FCF Ratio: 26.55x
Is Medline Inc.’s EV/FCF ratio high or low?
Medline Inc.'s EV/FCF ratio of 26.55x is in line with its 5-year average of 27.74x, near the low end of its 5-year range (24.25x–32.89x).
The EV/FCF ratio for Medline Inc. (MDLN) is 26.55x as of Thursday, June 11, 2026. It is below its 12-month average by 4.28% (27.74x).
MDLN EV/FCF Ratio Chart
MDLN Average EV/FCF Ratio Chart
MDLN Current vs Average EV/FCF Ratio Chart
MDLN EV/FCF Ratio Metrics
EV/FCF RATIO
26.55x
EV/FCF RATIO AVG TTM
27.74x
EV/FCF RATIO AVG 3Y
27.74x
EV/FCF RATIO AVG 5Y
27.74x
EV/FCF RATIO AVG 10Y
27.74x
EV/FCF RATIO AVG 15Y
27.74x
EV/FCF RATIO AVG 20Y
27.74x
CURRENT VS TTM AVG
-4.28%
CURRENT VS 3Y AVG
-4.28%
CURRENT VS 5Y AVG
-4.28%
CURRENT VS 10Y AVG
-4.28%
CURRENT VS 15Y AVG
-4.28%
CURRENT VS 20Y AVG
-4.28%
MDLN Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $30.90B | 26.55x | 27.74x | 27.74x | 27.74x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 11.54x | 19.19x | 27.03x | 27.69x |
| Centene Corporation (CNC) | $32.26B | 4.33x | 9.68x | 24.78x | 19.04x |
| Biogen Inc. (BIIB) | $28.94B | 12.26x | 12.72x | 21.64x | 21.17x |
| DexCom, Inc. (DXCM) | $28.92B | 20.82x | 37.28x | 66.76x | 181.49x |
| Zoetis Inc. (ZTS) | $34.27B | 19.58x | 28.10x | 41.99x | 48.24x |
| Veeva Systems Inc. (VEEV) | $26.73B | 48.97x | 29.32x | 32.91x | 38.27x |
| Agilent Technologies, Inc. (A) | $37.17B | 30.99x | 34.61x | 30.04x | 33.46x |
| Waters Corporation (WAT) | $23.60B | 131.87x | 43.74x | 43.15x | 41.51x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 31.58x | 33.77x | 33.51x | 38.37x |
Cash Flow Valuation Comparison
EV/FCF
26.6x
P/FCF
19.8x
FCF Yield
5.06%
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Medline Inc. EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medline Inc. EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Medline Inc. (MDLN)?
- The EV/FCF ratio for MDLN stock is 26.55x.
- Is Medline Inc.'s EV/FCF ratio high or low?
- Medline Inc.'s EV/FCF ratio of 26.55x is in line with its 5-year average of 27.74x, near the low end of its 5-year range (24.25x–32.89x).
- What is the TTM average EV/FCF ratio for Medline Inc. (MDLN)?
- The TTM average EV/FCF ratio for MDLN stock is 27.74x.
- What is the 3Y average EV/FCF ratio for Medline Inc. (MDLN)?
- The 3Y average EV/FCF ratio for MDLN stock is 27.74x.
- What is the 5Y average EV/FCF ratio for Medline Inc. (MDLN)?
- The 5Y average EV/FCF ratio for MDLN stock is 27.74x.
- What is the 10Y average EV/FCF ratio for Medline Inc. (MDLN)?
- The 10Y average EV/FCF ratio for MDLN stock is 27.74x.
- What is the 15Y average EV/FCF ratio for Medline Inc. (MDLN)?
- The 15Y average EV/FCF ratio for MDLN stock is 27.74x.
- What is the 20Y average EV/FCF ratio for Medline Inc. (MDLN)?
- The 20Y average EV/FCF ratio for MDLN stock is 27.74x.
Medline Inc. EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-06-10 | 26.55x |
| 2026-06-09 | 26.26x |
| 2026-06-08 | 25.06x |
| 2026-06-05 | 24.96x |
| 2026-06-04 | 25.41x |
| 2026-06-03 | 25.43x |
| 2026-06-02 | 24.73x |
| 2026-06-01 | 26.12x |
| 2026-05-29 | 26.56x |
| 2026-05-28 | 26.69x |
| 2026-05-27 | 26.17x |
| 2026-05-26 | 26.34x |
| 2026-05-22 | 26.80x |
| 2026-05-21 | 26.85x |
| 2026-05-20 | 26.39x |
| 2026-05-19 | 27.17x |
| 2026-05-18 | 26.26x |
| 2026-05-15 | 26.36x |
| 2026-05-14 | 27.82x |
| 2026-05-13 | 27.72x |
| 2026-05-12 | 27.63x |
| 2026-05-11 | 28.01x |
| 2026-05-08 | 28.16x |
| 2026-05-07 | 29.42x |
| 2026-05-06 | 29.50x |
| 2026-05-05 | 31.30x |
| 2026-05-04 | 30.68x |
| 2026-05-01 | 30.99x |
| 2026-04-30 | 30.84x |
| 2026-04-29 | 30.26x |
| 2026-04-28 | 30.71x |
| 2026-04-27 | 31.25x |
| 2026-04-24 | 30.99x |
| 2026-04-23 | 31.79x |
| 2026-04-22 | 32.29x |
| 2026-04-21 | 32.48x |
| 2026-04-20 | 32.89x |
| 2026-04-17 | 32.55x |
| 2026-04-16 | 32.17x |
| 2026-04-15 | 32.71x |
| 2026-04-14 | 32.57x |
| 2026-04-13 | 32.32x |
| 2026-04-10 | 31.45x |
| 2026-04-09 | 31.50x |
| 2026-04-08 | 30.76x |
| 2026-04-07 | 30.10x |
| 2026-04-06 | 30.52x |
| 2026-04-02 | 30.73x |
| 2026-04-01 | 30.58x |
| 2026-03-31 | 30.85x |
| 2026-03-30 | 29.83x |
| 2026-03-27 | 25.35x |
| 2026-03-26 | 25.74x |
| 2026-03-25 | 25.96x |
| 2026-03-24 | 25.66x |
| 2026-03-23 | 25.87x |
| 2026-03-20 | 25.99x |
| 2026-03-19 | 26.39x |
| 2026-03-18 | 25.77x |
| 2026-03-17 | 25.72x |
| 2026-03-16 | 25.53x |
| 2026-03-13 | 25.39x |
| 2026-03-12 | 25.21x |
| 2026-03-11 | 25.83x |
| 2026-03-10 | 26.06x |
| 2026-03-09 | 26.30x |
| 2026-03-06 | 26.50x |
| 2026-03-05 | 26.60x |
| 2026-03-04 | 26.06x |
| 2026-03-03 | 26.76x |
| 2026-03-02 | 27.44x |
| 2026-02-27 | 28.21x |
| 2026-02-26 | 28.85x |
| 2026-02-25 | 28.52x |
| 2026-02-24 | 29.37x |
| 2026-02-23 | 29.20x |
| 2026-02-20 | 29.28x |
| 2026-02-19 | 28.25x |
| 2026-02-18 | 28.30x |
| 2026-02-17 | 27.58x |
| 2026-02-13 | 26.83x |
| 2026-02-12 | 26.85x |
| 2026-02-11 | 27.06x |
| 2026-02-10 | 27.18x |
| 2026-02-09 | 28.15x |
| 2026-02-06 | 28.11x |
| 2026-02-05 | 27.60x |
| 2026-02-04 | 27.03x |
| 2026-02-03 | 26.91x |
| 2026-02-02 | 27.05x |
| 2026-01-30 | 26.67x |
| 2026-01-29 | 26.45x |
| 2026-01-28 | 26.73x |
| 2026-01-27 | 27.65x |
| 2026-01-26 | 26.97x |
| 2026-01-23 | 27.51x |
| 2026-01-22 | 27.49x |
| 2026-01-21 | 26.25x |
| 2026-01-20 | 26.65x |
| 2026-01-16 | 26.63x |
| 2026-01-15 | 25.98x |
| 2026-01-14 | 26.30x |
| 2026-01-13 | 26.04x |
| 2026-01-12 | 25.98x |
| 2026-01-09 | 24.96x |
| 2026-01-08 | 25.30x |
| 2026-01-07 | 24.91x |
| 2026-01-06 | 24.61x |
| 2026-01-05 | 24.25x |
| 2026-01-02 | 25.00x |
| 2025-12-31 | 25.65x |
| 2025-12-30 | 27.23x |
| 2025-12-29 | 27.27x |
| 2025-12-26 | 28.20x |
| 2025-12-24 | 28.27x |
| 2025-12-23 | 27.98x |
| 2025-12-22 | 27.35x |
| 2025-12-19 | 27.11x |
| 2025-12-18 | 26.17x |
| 2025-12-17 | 26.83x |
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle